시장보고서

상품코드

1761182

동물용 헬스케어 시장 : 시장 규모, 점유율, 동향, 성장 기회 분석 보고서 - 동물 유형별, 제품 유형별, 최종 사용자별, 지역별(2021-2031년)

Veterinary Healthcare Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Animal Type, Product Type, End User, and Geography

발행일: 2025년 06월 | 리서치사:

The Insight Partners | 페이지 정보: 영문 288 Pages | 배송안내 : 즉시배송

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

동물용 헬스케어 시장 규모는 2024년 934억 9,000만 달러로 평가되었고, 2031년에는 1,565억 3,000만 달러에 이를 것으로 예측되며, 2025-2031년 CAGR 7.7%로 예측되고 있습니다. 시장 성장을 촉진하는 주된 요인에는 인수 공통 감염증의 급증 및 동물의 건강에 대한 대처의 급등 등이 있습니다. 게다가 반려동물 사육의 증가, 가축 사육의 필요성 및 국제적인 질병 예방 프로그램은 예측 기간 동안 시장을 끌어올릴 가능성이 높습니다. 그러나 동물용 의약품의 개발 및 승인 과정의 복잡성과 비용의 높은 수준은 시장의 저해 요인 중 하나입니다.

HealthforAnimals의 '항생제 필요성을 줄이기 위한 로드맵' 프로그램에 따르면 2019년 이후 동물위생 분야의 연구개발 활동에 약 63억 달러가 투자되고 있습니다. 시장 기업은 혁신적인 제품을 도입하고 규제 당국의 승인을 확보하고 있습니다. 예를 들면, 연구 개발(R&D)은, 수의사와 축산 생산자의 장래의 요구를 선점한 혁신적인 동물용 의약품 솔루션을 제공하는 Zoetis의 대처의 중심이 되고 있습니다. 2024년 12월, 조에티스는 Veterinary Meeting & Expo(VMX) 2025에서 Vetscan OptiCell의 세계적 발매를 발표했습니다. 이는 카트리지식으로 인공지능(AI)을 탑재한 최초의 수의혈액학용 진단 도구로 몇 분 만에 정확한 인사이트를 가져오는 전혈구산정(CBC) 분석을 제공합니다. 이처럼 동물용 헬스케어 시장에서의 연구개발 노력 및 투자의 증가는 기술 혁신을 촉진하고 치료 옵션을 강화하며 질병 관리 능력을 향상시키고 있습니다.

질병관리센터(CDC)가 2024년 2월에 발표한 기사에 따르면 인간의 감염증의 60% 이상은 동물에서 감염될 가능성이 있으며, 인간의 신흥 감염증의 75%는 동물에서 유래합니다. 매년 인수 공통 감염병은 세계 25억 명의 사람 감염 및 270만 명의 사망을 일으키고 있습니다. 세계 동물보건기구(WOAH)에 따르면 사람의 질병을 일으키는 병원체의 약 60%는 가축 또는 야생동물에서 유래하고, 바이오테러 관련 병원체의 80%는 동물에서 유래합니다. 일반적인 인수 공통 감염병으로는 에볼라, 광견병, 살모넬라균, 탄저균, 라임병, 대장균, 조류독감 등이 있습니다. HIV는 인수 공통 감염증으로 발상하고, 그 후 사람에게만 변이되었습니다. 세계보건기구(WHO)에 따르면 가축 전염병은 세계 가축 생산량의 20% 이상을 잃고 축산에 의존하는 농촌 지역의 삶을 위협하고 있습니다. 인수 공통 감염증의 증가로 예방접종 및 진단검사 등 예방대책에 대한 수요가 높아지고 있습니다. 반려동물의 주인 및 농가가 가축을 보호하고 나아가 인간의 건강을 지키는 것을 목표로 하고 있기 때문입니다. 인수 공통 감염증의 관리 및 치료에 대한 대처는, 새로운 약이나 치료법의 개발에 박차를 가하고 있습니다. 이러한 치료 선택지의 확대는 기업이 이러한 건강 과제에 대처하기 위한 연구 개발에 투자함으로써 시장 성장에 기여하고 있습니다.

기업 분석에서는 제품 포트폴리오(제품 만족도, 제품 특징, 이용가능성), 최근 시장 동향(합병 및 인수, 신제품 출시 및 강화, 투자 및 자금 조달, 수상, 합의, 제휴 및 협력, 인지, 확대), 경쟁 구도의 보다 좋은 의사결정과 이해를 돕는 지역 현존을 바탕으로 동물용 헬스케어 시장을 평가하고 분류합니다. 본 보고서에서는, 세계의 동물용 헬스케어 시장에서 주요 벤더의 최근의 중요한 동향 및 혁신에 대해 깊이 조사하고 있습니다. 주요 시장 기업은 Boehringer Ingelheim International GmbH, Zoetis Inc, Merck &Co Inc, Shenzhen Mindray Animal Medical Technology Co.LTD, Neogen Corp, Idexx Laboratories Inc, Elanco Animal Health Inc, HIPRA SA, Ceva Sante Animale, Antech Diagnostics, Inc.입니다.

동물 유형에 따라 동물용 헬스케어 시장은 컴패니언, 가축, 가금으로 나뉩니다. 2024년 동물용 헬스케어 시장에서는 가축 및 가금 부문이 가장 큰 점유율을 차지했습니다.

제품 유형별로 세계의 동물용 헬스케어 시장은 의약품, 의료기기, 사료 첨가물로 구분됩니다. 의약품 부문이 2024년 동물용 헬스케어 시장에서 가장 큰 점유율을 차지했습니다.

최종 사용자별로, 세계의 동물용 헬스케어 시장은 동물 병원, 진료소, 기타로 분류됩니다. 동물 병원 부문은 2024년에 동물용 헬스케어 시장에서 가장 큰 점유율을 차지했습니다. 동물 병원은 예방 접종 서비스 및 예방 접종 일정에 관한 전문적인 조언을 제공하고 있습니다. 동물 병원은 바이러스 벡터나 결합 백신 등의 혁신적인 백신을 제공하고 있습니다. 이러한 기관은 종종 새로운 기술과 제품을 채택하여 새로운 백신 제제의 사용을 추진하고 있습니다. 반려동물 주인 및 축산 농가가 동물 병원에 접근하는 신뢰가 백신의 보급을 뒷받침하고 있는 것입니다. 미국 홈타운병원의 전국 네트워크인 VCA 동물 병원은 광견병, 디스템퍼, 아데노바이러스(개전염성 간염), 파르보바이러스, 렙토스피라증, 파라인플루엔자, 코로나바이러스, 기관지염 보르데테라, 라임병, 개 인플루엔자 등의 백신을 제공하고 있습니다. 수의사는 백신 선택과 투여에 관한 지도를 하여 동물들이 적절한 예방접종을 받을 수 있도록 하고 있습니다. 더불어 동물병원은 엄격한 규제기준을 준수하여 백신이 안전하고 효과적으로 투여될 수 있도록 하고 있습니다. 이러한 컴플라이언스는 동물 의료에 대한 사회적 신뢰 유지에 도움이 되고 있습니다.

동물용 헬스케어 시장에서 사업을 전개하는 기업은 다양한 유기적 및 무기적 전략을 채용하고 있습니다. 유기적 전략에는 주로 제품 출시와 제품 승인이 포함됩니다. 시장에서 볼 수 있는 무기적 성장 전략에는 인수, 제휴, 파트너십 등이 있습니다. 이러한 성장 전략에 의해, 시장 참가 기업은 사업을 확대해, 지리적 존재감을 높이는 것과 동시에, 시장 전체의 성장에 공헌할 수 있습니다. 게다가 인수나 제휴 등의 전략은 고객 기반을 강화하고 제품 포트폴리오를 확대하는 데 도움이 되고 있습니다. 동물용 헬스케어 시장의 주요 기업에 의한 주요 발전의 몇 가지를 이하에 제시합니다.

2025년, Mindray Animal Medical사는 유럽에 최초의 지점을 설립. 민드레이와 그 자회사인 민드레이 동물 메디컬은 유럽에서 게이트웨이로 네덜란드를 선택했습니다. Mindray Animal Medical의 경우 네덜란드는 유럽의 허브이며 물류, 연구개발, 애프터세일즈, 교육 서비스 지원 센터입니다.

2025년 세바는 프랑스에 바이오 제노백 유전체학 연구소를 개설했습니다. 이 첨단 시설은 첨단 유전체 기술 및 바이오인포매틱스를 활용한 미래의 백신 개발에 특화되어 있습니다. 이 연구소는 동물의 새로운 감염에 신속하게 대응할 수 있는 맞춤형 백신 솔루션을 생산하는 것을 목표로 합니다.

동물용 헬스케어 시장-주요 시장 역학
시장 성장 촉진요인
- 인수 공통 감염증 급증
- 동물 건강에 대한 이니셔티브의 고조
시장 성장 억제요인
- 동물용 의약품 개발 및 승인 프로세스의 복잡성과 높은 비용
시장 기회
- 연구개발 활동의 활성화
향후 동향
- 동물용 헬스케어에서 기술의 진보
성장 촉진요인 및 억제요인의 영향

제6장 세계의 동물용 헬스케어 시장 : 시장 분석

동물용 헬스케어 시장의 수익(2021-2031년)
동물용 헬스케어 시장 예측 분석

제7장 동물용 헬스케어 시장 분석 : 동물 유형별

반려동물
가축 및 가금

제8장 동물용 헬스케어 시장 분석 : 제품 유형별

의약품
의료기기
사료 첨가물

제9장 동물용 헬스케어 시장 분석 : 최종 사용자별

동물병원
진료소
기타

제10장 동물용 헬스케어 시장 : 지역별

북미
- 미국
- 캐나다
- 멕시코
유럽
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 기타 유럽
아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- 아시아태평양의 기타 국가
중동 및 아프리카
- 남아프리카
- 사우디아라비아
- 아랍에미리트(UAE)
- 기타 중동 및 아프리카
중남미
- 브라질
- 아르헨티나
- 기타 중남미

제11장 업계 정세

사업 확대
신제품 개발
합병 및 인수
파트너십

제12장 기업 프로파일

Zoetis Inc
Elanco Animal Health Inc
Boehringer Ingelheim International GmbH
Idexx Laboratories Inc
Antech Diagnostics, Inc
Ceva Sante Animale
Shenzhen Mindray Animal Medical Technology Co., LTD
HIPRA SA
Neogen Corp
Merck & Co Inc

제13장 부록

AJY 25.07.10

The veterinary Healthcare market size is projected to reach US$ 156.53 billion by 2031 from US$ 93.49 billion in 2024; it is estimated to register a CAGR of 7.7% during 2025-2031. Major factors driving the market growth include surging prevalence of zoonotic diseases and soaring initiatives for animal health. Further, the increasing pet ownership, livestock husbandry requirements, and international disease prevention programs is likely to boost the market during the forecast period. However high complexity and cost of veterinary drug development and approval processes are among the market deterrents.

According to the "Roadmap to Reducing the Need for Antibiotics" program by HealthforAnimals, approximately US $6.3 billion has been invested in research and development activities in the animal health sector since 2019. Market players are introducing innovative products and securing regulatory approvals for the same. For instance, research and development (R&D) is at the center of Zoetis' efforts to provide innovative animal health solutions that anticipate the future needs of veterinarians and livestock producers. In December 2024, Zoetis announced the global launch of Vetscan OptiCell at the Veterinary Meeting & Expo (VMX) 2025. It is the first cartridge-based, artificial intelligence (AI) powered diagnostic tool for veterinary hematology, providing complete blood count (CBC) analysis that delivers accurate insights in minutes. Thus, the increasing R&D efforts and investments in the animal healthcare market are fostering innovation, enhancing treatment options, and improving disease management capabilities.

According to an article published by the Center for Disease Control (CDC) in February 2024, over 60% of infectious diseases in humans can be transmitted from animals, and 75% of emerging infectious diseases in humans originate from animals. Each year, zoonotic diseases cause 2.5 billion human infections and 2.7 million deaths worldwide. According to the World Organization for Animal Health (WOAH), about 60% of pathogens causing human diseases come from domestic animals or wildlife, and 80% of bioterrorism-related pathogens originate from animals. Common zoonotic diseases include Ebola, rabies, salmonella, anthrax, Lyme disease, E. coli, and bird flu. HIV originated as a zoonosis before mutating into human-only strains. As per the World Health Organization (WHO), animal diseases lead to over 20% of global production losses in livestock, threatening the livelihoods of rural communities dependent on animal agriculture. The increasing incidences of zoonotic diseases are propelling the demand for preventive measures, including vaccinations and diagnostic tests. This increased demand is driving the emphasis on animal healthcare products and services, as pet owners and farmers aim to protect their animals and, in turn, safeguard human health. Efforts to manage and treat zoonotic diseases have fueled the development of new medications and treatments. This expansion in treatment options contributes to market growth as companies invest in research and development to address these health challenges.

The company analysis evaluates and categorizes the veterinary healthcare market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global veterinary healthcare market. The key market players are Boehringer Ingelheim International GmbH, Zoetis Inc, Merck & Co Inc, Shenzhen Mindray Animal Medical Technology Co., LTD, Neogen Corp, Idexx Laboratories Inc, Elanco Animal Health Inc, HIPRA SA, Ceva Sante Animale, and Antech Diagnostics, Inc.

Based on animal type, the veterinary healthcare market is divided into companion, livestock, and poultry. The livestock and poultry segment held the largest share of the veterinary healthcare market in 2024.

By product type, the global veterinary healthcare market is segmented into pharmaceuticals, medical devices, and feed additives. The pharmaceuticals segment held the largest share of the veterinary healthcare market in 2024.

By end user, the global veterinary healthcare market is categorized into veterinary hospitals, clinics, and others. The veterinary hospitals segment held the largest share of the veterinary healthcare market in 2024. Veterinary hospitals offer vaccination services and expert advice on immunization schedules. They provide innovative vaccines such as viral vectors and conjugated vaccines. These institutions often adopt new technologies and products and promote the use of novel vaccine formulations. The trust placed in veterinary hospitals by pet owners and livestock farmers enhances vaccine adoption. VCA Animal Hospitals, a national network of hometown hospitals in the US, offer vaccines, including rabies, distemper, adenovirus (infectious canine hepatitis), parvovirus, leptospirosis, parainfluenza, coronavirus, Bordetella bronchiseptica, Lyme disease, and canine influenza. Veterinarians provide guidance on vaccine selection and administration, ensuring that animals receive appropriate immunizations. Additionally, veterinary hospitals adhere to strict regulatory standards, ensuring that vaccines are administered safely and effectively. This compliance helps maintain public trust in veterinary care.

Various organic and inorganic strategies are adopted by companies operating in the veterinary healthcare market. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaboration, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, along with contributing to the overall market growth. Furthermore, strategies such as acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few of the significant developments by key players in the veterinary healthcare market are listed below.

In 2025, Mindray Animal Medical Established the First Branch in Europe. Mindray and its subsidiary, Mindray Animal Medical, selected the Netherlands as the gateway in Europe. For Mindray Animal Medical, the Netherlands is the hub for Europe and the support center for logistics, R&D, after-sales, and training services.

In 2025, Ceva inaugurated the Biogenovac genomics laboratory in France. This state-of-the-art facility is dedicated to developing future vaccines by leveraging advanced genomic technologies and bioinformatics. The laboratory aims to create tailored vaccine solutions that can rapidly respond to emerging infectious diseases in animals.

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Analyst Market Outlook

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
3.3 Assumptions and Limitations

4. Veterinary Healthcare Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Veterinary Healthcare Market - Key Market Dynamics

5.1 Veterinary Healthcare Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Surging Prevalence of Zoonotic Diseases
- 5.2.2 Growing Initiatives for Animal Health
5.3 Market Restraints
- 5.3.1 High Complexity and Cost of Veterinary Drug Development and Approval Processes
5.4 Market Opportunities
- 5.4.1 Increasing Research and Development Activities
5.5 Future Trends
- 5.5.1 Technological Advancements in Veterinary Healthcare
5.6 Impact of Drivers and Restraints:

6. Veterinary Healthcare Market - Global Market Analysis

6.1 Veterinary Healthcare Market Revenue (US$ Million), 2021-2031
6.2 Veterinary Healthcare Market Forecast Analysis

7. Veterinary Healthcare Market Analysis - by Animal Type

7.1 Companion
- 7.1.1 Overview
- 7.1.2 Companion: Veterinary Healthcare Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Livestock and Poultry
- 7.2.1 Overview
- 7.2.2 Livestock and Poultry: Veterinary Healthcare Market - Revenue and Forecast to 2031 (US$ Million)

8. Veterinary Healthcare Market Analysis - by Product Type

8.1 Pharmaceuticals
- 8.1.1 Overview
- 8.1.2 Pharmaceuticals: Veterinary Healthcare Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Medical Devices
- 8.2.1 Overview
- 8.2.2 Medical Devices: Veterinary Healthcare Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Feed Additives
- 8.3.1 Overview
- 8.3.2 Feed Additives: Veterinary Healthcare Market - Revenue and Forecast to 2031 (US$ Million)

9. Veterinary Healthcare Market Analysis - by End User

9.1 Veterinary Hospitals
- 9.1.1 Overview
- 9.1.2 Veterinary Hospitals: Veterinary Healthcare Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Clinics
- 9.2.1 Overview
- 9.2.2 Clinics: Veterinary Healthcare Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Others
- 9.3.1 Overview
- 9.3.2 Others: Veterinary Healthcare Market - Revenue and Forecast to 2031 (US$ Million)

10. Veterinary Healthcare Market - Geographical Analysis

10.1 North America
- 10.1.1 North America Veterinary Healthcare Market Overview
- 10.1.2 North America: Veterinary Healthcare Market - Revenue, 2021-2031 (US$ Million)
  - 10.1.2.1 North America: Veterinary Healthcare Market - Revenue and Forecast Analysis - by Animal Type
  - 10.1.2.2 North America: Veterinary Healthcare Market - Revenue and Forecast Analysis - by Companion
  - 10.1.2.3 North America: Veterinary Healthcare Market - Revenue and Forecast Analysis - by Livestock And Poultry
  - 10.1.2.4 North America: Veterinary Healthcare Market - Revenue and Forecast Analysis - by Product Type
  - 10.1.2.5 North America: Veterinary Healthcare Market - Revenue and Forecast Analysis - by Pharmaceuticals
  - 10.1.2.6 North America: Veterinary Healthcare Market - Revenue and Forecast Analysis - by End User
- 10.1.3 North America: Veterinary Healthcare Market - Revenue and Forecast Analysis - by Country
  - 10.1.3.1 United States: Veterinary Healthcare Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.3.1.1 United States: Veterinary Healthcare Market Breakdown, by Animal Type
    - 10.1.3.1.2 United States: Veterinary Healthcare Market Breakdown, by Companion
    - 10.1.3.1.3 United States: Veterinary Healthcare Market Breakdown, by Livestock And Poultry
    - 10.1.3.1.4 United States: Veterinary Healthcare Market Breakdown, by Product Type
    - 10.1.3.1.5 United States: Veterinary Healthcare Market Breakdown, by Pharmaceuticals
    - 10.1.3.1.6 United States: Veterinary Healthcare Market Breakdown, by End User
  - 10.1.3.2 Canada: Veterinary Healthcare Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.3.2.1 Canada: Veterinary Healthcare Market Breakdown, by Animal Type
    - 10.1.3.2.2 Canada: Veterinary Healthcare Market Breakdown, by Companion
    - 10.1.3.2.3 Canada: Veterinary Healthcare Market Breakdown, by Livestock And Poultry
    - 10.1.3.2.4 Canada: Veterinary Healthcare Market Breakdown, by Product Type
    - 10.1.3.2.5 Canada: Veterinary Healthcare Market Breakdown, by Pharmaceuticals
    - 10.1.3.2.6 Canada: Veterinary Healthcare Market Breakdown, by End User
  - 10.1.3.3 Mexico: Veterinary Healthcare Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.3.3.1 Mexico: Veterinary Healthcare Market Breakdown, by Animal Type
    - 10.1.3.3.2 Mexico: Veterinary Healthcare Market Breakdown, by Companion
    - 10.1.3.3.3 Mexico: Veterinary Healthcare Market Breakdown, by Livestock And Poultry
    - 10.1.3.3.4 Mexico: Veterinary Healthcare Market Breakdown, by Product Type
    - 10.1.3.3.5 Mexico: Veterinary Healthcare Market Breakdown, by Pharmaceuticals
    - 10.1.3.3.6 Mexico: Veterinary Healthcare Market Breakdown, by End User
10.2 Europe
- 10.2.1 Europe Veterinary Healthcare Market Overview
- 10.2.2 Europe: Veterinary Healthcare Market - Revenue, 2021-2031 (US$ Million)
  - 10.2.2.1 Europe: Veterinary Healthcare Market - Revenue and Forecast Analysis - by Animal Type
  - 10.2.2.2 Europe: Veterinary Healthcare Market - Revenue and Forecast Analysis - by Companion
  - 10.2.2.3 Europe: Veterinary Healthcare Market - Revenue and Forecast Analysis - by Livestock And Poultry
  - 10.2.2.4 Europe: Veterinary Healthcare Market - Revenue and Forecast Analysis - by Product Type
  - 10.2.2.5 Europe: Veterinary Healthcare Market - Revenue and Forecast Analysis - by Pharmaceuticals
  - 10.2.2.6 Europe: Veterinary Healthcare Market - Revenue and Forecast Analysis - by End User
- 10.2.3 Europe: Veterinary Healthcare Market - Revenue and Forecast Analysis - by Country
  - 10.2.3.1 Germany: Veterinary Healthcare Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.1.1 Germany: Veterinary Healthcare Market Breakdown, by Animal Type
    - 10.2.3.1.2 Germany: Veterinary Healthcare Market Breakdown, by Companion
    - 10.2.3.1.3 Germany: Veterinary Healthcare Market Breakdown, by Livestock And Poultry
    - 10.2.3.1.4 Germany: Veterinary Healthcare Market Breakdown, by Product Type
    - 10.2.3.1.5 Germany: Veterinary Healthcare Market Breakdown, by Pharmaceuticals
    - 10.2.3.1.6 Germany: Veterinary Healthcare Market Breakdown, by End User
  - 10.2.3.2 United Kingdom: Veterinary Healthcare Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.2.1 United Kingdom: Veterinary Healthcare Market Breakdown, by Animal Type
    - 10.2.3.2.2 United Kingdom: Veterinary Healthcare Market Breakdown, by Companion
    - 10.2.3.2.3 United Kingdom: Veterinary Healthcare Market Breakdown, by Livestock And Poultry
    - 10.2.3.2.4 United Kingdom: Veterinary Healthcare Market Breakdown, by Product Type
    - 10.2.3.2.5 United Kingdom: Veterinary Healthcare Market Breakdown, by Pharmaceuticals
    - 10.2.3.2.6 United Kingdom: Veterinary Healthcare Market Breakdown, by End User
  - 10.2.3.3 France: Veterinary Healthcare Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.3.1 France: Veterinary Healthcare Market Breakdown, by Animal Type
    - 10.2.3.3.2 France: Veterinary Healthcare Market Breakdown, by Companion
    - 10.2.3.3.3 France: Veterinary Healthcare Market Breakdown, by Livestock And Poultry
    - 10.2.3.3.4 France: Veterinary Healthcare Market Breakdown, by Product Type
    - 10.2.3.3.5 France: Veterinary Healthcare Market Breakdown, by Pharmaceuticals
    - 10.2.3.3.6 France: Veterinary Healthcare Market Breakdown, by End User
  - 10.2.3.4 Italy: Veterinary Healthcare Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.4.1 Italy: Veterinary Healthcare Market Breakdown, by Animal Type
    - 10.2.3.4.2 Italy: Veterinary Healthcare Market Breakdown, by Companion
    - 10.2.3.4.3 Italy: Veterinary Healthcare Market Breakdown, by Livestock And Poultry
    - 10.2.3.4.4 Italy: Veterinary Healthcare Market Breakdown, by Product Type
    - 10.2.3.4.5 Italy: Veterinary Healthcare Market Breakdown, by Pharmaceuticals
    - 10.2.3.4.6 Italy: Veterinary Healthcare Market Breakdown, by End User
  - 10.2.3.5 Spain: Veterinary Healthcare Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.5.1 Spain: Veterinary Healthcare Market Breakdown, by Animal Type
    - 10.2.3.5.2 Spain: Veterinary Healthcare Market Breakdown, by Companion
    - 10.2.3.5.3 Spain: Veterinary Healthcare Market Breakdown, by Livestock And Poultry
    - 10.2.3.5.4 Spain: Veterinary Healthcare Market Breakdown, by Product Type
    - 10.2.3.5.5 Spain: Veterinary Healthcare Market Breakdown, by Pharmaceuticals
    - 10.2.3.5.6 Spain: Veterinary Healthcare Market Breakdown, by End User
  - 10.2.3.6 Rest of Europe: Veterinary Healthcare Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.6.1 Rest of Europe: Veterinary Healthcare Market Breakdown, by Animal Type
    - 10.2.3.6.2 Rest of Europe: Veterinary Healthcare Market Breakdown, by Companion
    - 10.2.3.6.3 Rest of Europe: Veterinary Healthcare Market Breakdown, by Livestock And Poultry
    - 10.2.3.6.4 Rest of Europe: Veterinary Healthcare Market Breakdown, by Product Type
    - 10.2.3.6.5 Rest of Europe: Veterinary Healthcare Market Breakdown, by Pharmaceuticals
    - 10.2.3.6.6 Rest of Europe: Veterinary Healthcare Market Breakdown, by End User
10.3 Asia Pacific
- 10.3.1 Asia Pacific Veterinary Healthcare Market Overview
- 10.3.2 Asia Pacific: Veterinary Healthcare Market - Revenue, 2021-2031 (US$ Million)
  - 10.3.2.1 Asia Pacific: Veterinary Healthcare Market - Revenue and Forecast Analysis - by Animal Type
  - 10.3.2.2 Asia Pacific: Veterinary Healthcare Market - Revenue and Forecast Analysis - by Companion
  - 10.3.2.3 Asia Pacific: Veterinary Healthcare Market - Revenue and Forecast Analysis - by Livestock And Poultry
  - 10.3.2.4 Asia Pacific: Veterinary Healthcare Market - Revenue and Forecast Analysis - by Product Type
  - 10.3.2.5 Asia Pacific: Veterinary Healthcare Market - Revenue and Forecast Analysis - by Pharmaceuticals
  - 10.3.2.6 Asia Pacific: Veterinary Healthcare Market - Revenue and Forecast Analysis - by End User
- 10.3.3 Asia Pacific: Veterinary Healthcare Market - Revenue and Forecast Analysis - by Country
  - 10.3.3.1 China: Veterinary Healthcare Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.1.1 China: Veterinary Healthcare Market Breakdown, by Animal Type
    - 10.3.3.1.2 China: Veterinary Healthcare Market Breakdown, by Companion
    - 10.3.3.1.3 China: Veterinary Healthcare Market Breakdown, by Livestock And Poultry
    - 10.3.3.1.4 China: Veterinary Healthcare Market Breakdown, by Product Type
    - 10.3.3.1.5 China: Veterinary Healthcare Market Breakdown, by Pharmaceuticals
    - 10.3.3.1.6 China: Veterinary Healthcare Market Breakdown, by End User
  - 10.3.3.2 India: Veterinary Healthcare Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.2.1 India: Veterinary Healthcare Market Breakdown, by Animal Type
    - 10.3.3.2.2 India: Veterinary Healthcare Market Breakdown, by Companion
    - 10.3.3.2.3 India: Veterinary Healthcare Market Breakdown, by Livestock And Poultry
    - 10.3.3.2.4 India: Veterinary Healthcare Market Breakdown, by Product Type
    - 10.3.3.2.5 India: Veterinary Healthcare Market Breakdown, by Pharmaceuticals
    - 10.3.3.2.6 India: Veterinary Healthcare Market Breakdown, by End User
  - 10.3.3.3 Japan: Veterinary Healthcare Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.3.1 Japan: Veterinary Healthcare Market Breakdown, by Animal Type
    - 10.3.3.3.2 Japan: Veterinary Healthcare Market Breakdown, by Companion
    - 10.3.3.3.3 Japan: Veterinary Healthcare Market Breakdown, by Livestock And Poultry
    - 10.3.3.3.4 Japan: Veterinary Healthcare Market Breakdown, by Product Type
    - 10.3.3.3.5 Japan: Veterinary Healthcare Market Breakdown, by Pharmaceuticals
    - 10.3.3.3.6 Japan: Veterinary Healthcare Market Breakdown, by End User
  - 10.3.3.4 Australia: Veterinary Healthcare Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.4.1 Australia: Veterinary Healthcare Market Breakdown, by Animal Type
    - 10.3.3.4.2 Australia: Veterinary Healthcare Market Breakdown, by Companion
    - 10.3.3.4.3 Australia: Veterinary Healthcare Market Breakdown, by Livestock And Poultry
    - 10.3.3.4.4 Australia: Veterinary Healthcare Market Breakdown, by Product Type
    - 10.3.3.4.5 Australia: Veterinary Healthcare Market Breakdown, by Pharmaceuticals
    - 10.3.3.4.6 Australia: Veterinary Healthcare Market Breakdown, by End User
  - 10.3.3.5 South Korea: Veterinary Healthcare Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.5.1 South Korea: Veterinary Healthcare Market Breakdown, by Animal Type
    - 10.3.3.5.2 South Korea: Veterinary Healthcare Market Breakdown, by Companion
    - 10.3.3.5.3 South Korea: Veterinary Healthcare Market Breakdown, by Livestock And Poultry
    - 10.3.3.5.4 South Korea: Veterinary Healthcare Market Breakdown, by Product Type
    - 10.3.3.5.5 South Korea: Veterinary Healthcare Market Breakdown, by Pharmaceuticals
    - 10.3.3.5.6 South Korea: Veterinary Healthcare Market Breakdown, by End User
  - 10.3.3.6 Rest of APAC: Veterinary Healthcare Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.6.1 Rest of APAC: Veterinary Healthcare Market Breakdown, by Animal Type
    - 10.3.3.6.2 Rest of APAC: Veterinary Healthcare Market Breakdown, by Companion
    - 10.3.3.6.3 Rest of APAC: Veterinary Healthcare Market Breakdown, by Livestock And Poultry
    - 10.3.3.6.4 Rest of APAC: Veterinary Healthcare Market Breakdown, by Product Type
    - 10.3.3.6.5 Rest of APAC: Veterinary Healthcare Market Breakdown, by Pharmaceuticals
    - 10.3.3.6.6 Rest of APAC: Veterinary Healthcare Market Breakdown, by End User
10.4 Middle East and Africa
- 10.4.1 Middle East and Africa Veterinary Healthcare Market Overview
- 10.4.2 Middle East and Africa: Veterinary Healthcare Market - Revenue, 2021-2031 (US$ Million)
  - 10.4.2.1 Middle East and Africa: Veterinary Healthcare Market - Revenue and Forecast Analysis - by Animal Type
  - 10.4.2.2 Middle East and Africa: Veterinary Healthcare Market - Revenue and Forecast Analysis - by Companion
  - 10.4.2.3 Middle East and Africa: Veterinary Healthcare Market - Revenue and Forecast Analysis - by Livestock And Poultry
  - 10.4.2.4 Middle East and Africa: Veterinary Healthcare Market - Revenue and Forecast Analysis - by Product Type
  - 10.4.2.5 Middle East and Africa: Veterinary Healthcare Market - Revenue and Forecast Analysis - by Pharmaceuticals
  - 10.4.2.6 Middle East and Africa: Veterinary Healthcare Market - Revenue and Forecast Analysis - by End User
- 10.4.3 Middle East and Africa: Veterinary Healthcare Market - Revenue and Forecast Analysis - by Country
  - 10.4.3.1 South Africa: Veterinary Healthcare Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.1.1 South Africa: Veterinary Healthcare Market Breakdown, by Animal Type
    - 10.4.3.1.2 South Africa: Veterinary Healthcare Market Breakdown, by Companion
    - 10.4.3.1.3 South Africa: Veterinary Healthcare Market Breakdown, by Livestock And Poultry
    - 10.4.3.1.4 South Africa: Veterinary Healthcare Market Breakdown, by Product Type
    - 10.4.3.1.5 South Africa: Veterinary Healthcare Market Breakdown, by Pharmaceuticals
    - 10.4.3.1.6 South Africa: Veterinary Healthcare Market Breakdown, by End User
  - 10.4.3.2 Saudi Arabia: Veterinary Healthcare Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.2.1 Saudi Arabia: Veterinary Healthcare Market Breakdown, by Animal Type
    - 10.4.3.2.2 Saudi Arabia: Veterinary Healthcare Market Breakdown, by Companion
    - 10.4.3.2.3 Saudi Arabia: Veterinary Healthcare Market Breakdown, by Livestock And Poultry
    - 10.4.3.2.4 Saudi Arabia: Veterinary Healthcare Market Breakdown, by Product Type
    - 10.4.3.2.5 Saudi Arabia: Veterinary Healthcare Market Breakdown, by Pharmaceuticals
    - 10.4.3.2.6 Saudi Arabia: Veterinary Healthcare Market Breakdown, by End User
  - 10.4.3.3 United Arab Emirates: Veterinary Healthcare Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.3.1 United Arab Emirates: Veterinary Healthcare Market Breakdown, by Animal Type
    - 10.4.3.3.2 United Arab Emirates: Veterinary Healthcare Market Breakdown, by Companion
    - 10.4.3.3.3 United Arab Emirates: Veterinary Healthcare Market Breakdown, by Livestock And Poultry
    - 10.4.3.3.4 United Arab Emirates: Veterinary Healthcare Market Breakdown, by Product Type
    - 10.4.3.3.5 United Arab Emirates: Veterinary Healthcare Market Breakdown, by Pharmaceuticals
    - 10.4.3.3.6 United Arab Emirates: Veterinary Healthcare Market Breakdown, by End User
  - 10.4.3.4 Rest of Middle East and Africa: Veterinary Healthcare Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.4.1 Rest of Middle East and Africa: Veterinary Healthcare Market Breakdown, by Animal Type
    - 10.4.3.4.2 Rest of Middle East and Africa: Veterinary Healthcare Market Breakdown, by Companion
    - 10.4.3.4.3 Rest of Middle East and Africa: Veterinary Healthcare Market Breakdown, by Livestock And Poultry
    - 10.4.3.4.4 Rest of Middle East and Africa: Veterinary Healthcare Market Breakdown, by Product Type
    - 10.4.3.4.5 Rest of Middle East and Africa: Veterinary Healthcare Market Breakdown, by Pharmaceuticals
    - 10.4.3.4.6 Rest of Middle East and Africa: Veterinary Healthcare Market Breakdown, by End User
10.5 South and Central America
- 10.5.1 South and Central America Veterinary Healthcare Market Overview
- 10.5.2 South and Central America: Veterinary Healthcare Market - Revenue, 2021-2031 (US$ Million)
  - 10.5.2.1 South and Central America: Veterinary Healthcare Market - Revenue and Forecast Analysis - by Animal Type
  - 10.5.2.2 South and Central America: Veterinary Healthcare Market - Revenue and Forecast Analysis - by Companion
  - 10.5.2.3 South and Central America: Veterinary Healthcare Market - Revenue and Forecast Analysis - by Livestock And Poultry
  - 10.5.2.4 South and Central America: Veterinary Healthcare Market - Revenue and Forecast Analysis - by Product Type
  - 10.5.2.5 South and Central America: Veterinary Healthcare Market - Revenue and Forecast Analysis - by Pharmaceuticals
  - 10.5.2.6 South and Central America: Veterinary Healthcare Market - Revenue and Forecast Analysis - by End User
- 10.5.3 South and Central America: Veterinary Healthcare Market - Revenue and Forecast Analysis - by Country
  - 10.5.3.1 Brazil: Veterinary Healthcare Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.5.3.1.1 Brazil: Veterinary Healthcare Market Breakdown, by Animal Type
    - 10.5.3.1.2 Brazil: Veterinary Healthcare Market Breakdown, by Companion
    - 10.5.3.1.3 Brazil: Veterinary Healthcare Market Breakdown, by Livestock And Poultry
    - 10.5.3.1.4 Brazil: Veterinary Healthcare Market Breakdown, by Product Type
    - 10.5.3.1.5 Brazil: Veterinary Healthcare Market Breakdown, by Pharmaceuticals
    - 10.5.3.1.6 Brazil: Veterinary Healthcare Market Breakdown, by End User
  - 10.5.3.2 Argentina: Veterinary Healthcare Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.5.3.2.1 Argentina: Veterinary Healthcare Market Breakdown, by Animal Type
    - 10.5.3.2.2 Argentina: Veterinary Healthcare Market Breakdown, by Companion
    - 10.5.3.2.3 Argentina: Veterinary Healthcare Market Breakdown, by Livestock And Poultry
    - 10.5.3.2.4 Argentina: Veterinary Healthcare Market Breakdown, by Product Type
    - 10.5.3.2.5 Argentina: Veterinary Healthcare Market Breakdown, by Pharmaceuticals
    - 10.5.3.2.6 Argentina: Veterinary Healthcare Market Breakdown, by End User
  - 10.5.3.3 Rest of South and Central America: Veterinary Healthcare Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.5.3.3.1 Rest of South and Central America: Veterinary Healthcare Market Breakdown, by Animal Type
    - 10.5.3.3.2 Rest of South and Central America: Veterinary Healthcare Market Breakdown, by Companion
    - 10.5.3.3.3 Rest of South and Central America: Veterinary Healthcare Market Breakdown, by Livestock And Poultry
    - 10.5.3.3.4 Rest of South and Central America: Veterinary Healthcare Market Breakdown, by Product Type
    - 10.5.3.3.5 Rest of South and Central America: Veterinary Healthcare Market Breakdown, by Pharmaceuticals
    - 10.5.3.3.6 Rest of South and Central America: Veterinary Healthcare Market Breakdown, by End User

11. Industry Landscape

11.1 Overview
11.2 Expansion
11.3 New Product Development
11.4 Merger and Acquisition
11.5 Partnerships

12. Company Profiles

12.1 Zoetis Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Elanco Animal Health Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Boehringer Ingelheim International GmbH
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Idexx Laboratories Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Antech Diagnostics, Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Ceva Sante Animale
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Shenzhen Mindray Animal Medical Technology Co., LTD
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 HIPRA SA
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Neogen Corp
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Merck & Co Inc
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms